Bone Mineral Density in Chronic Liver Disease Patients: High Prevalence of Osteopenia and Osteoporosis in Patients of Advanced Cirrhosis
Osteopenia
Chronic liver disease
Liver disease
Bone disease
DOI:
10.4103/ajim.ajim_3_24
Publication Date:
2025-05-12T10:00:29Z
AUTHORS (6)
ABSTRACT
Abstract Background: Hepatic osteodystrophy is a well-known metabolic bone complication in individuals with chronic liver disease (CLD). The pathophysiology unknown, and evidence of increased risk osteoporosis osteopenia CLD inconsistent. Objective: present study aims to describe the mineral density patients explore its association severity disease. Materials Methods: Sixty confirmed cirrhosis were enrolled this study. All underwent laboratory measurements densitometry (BMD) using dual X-ray absorptiometry. Results: Low BMD was found 43 (71.66%) patients, only 17 (28.33%) had normal BMD. causes hepatitis B 12 (20%) C 11 (18.33%), cryptogenic 37 (61.66%) patients. Out 26 (43.33%) osteoporosis. A statistically significant difference between low marrow terms calcium bilirubin levels. serum high levels as compared those Bone worsens worsening (Child [ n = 14/14, 100%], Child 17/19, 89%], 12/27, 45%]). Conclusion: showed that highly prevalent variable etiologies. progresses directly correlates Child–Turcotte–Pugh (CTP) score. Due prevalence, these should undergo routine assessment if required, be treated for before their CTP score worsens.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (26)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....